Navigation Links
JumpStart Invests in Checkpoint Surgical
Date:11/10/2009

nths leading up to a full commercial launch in mid 2010."

This is JumpStart Ventures' 54th investment in its 41st company. Other healthcare companies in JumpStart Ventures' portfolio include AnalizaDx, CardioInsight Technologies, CerviLenz, Freedom Meditech, Great Lakes Pharmaceuticals, Juventas Therapeutics, Neuros Medical, Synapse Biomedical, Tursiop Technologies, and VasoLux MicroSystems.

About Checkpoint Surgical LLC

The mission of Checkpoint Surgical (www.checkpointsurgical.com) is to provide physicians with medical devices to locate, evaluate and protect nerves and muscles in surgical procedures for better patient outcomes. The Company's flagship product, the CHECKPOINT® Stimulator/Locator is a single-use, hand-held stimulator with a broad range of stimulation parameters that are fully controllable by the surgeon. The CHECKPOINT® Stimulator/Locator was designed by a world class team of orthopaedic surgeons and biomedical engineers working together to provide surgeons with a simple, safe, versatile tool to help locate, identify and evaluate nerves in the surgical site and make surgical decisions with confidence. Beyond this initial product, the Checkpoint surgical team is dedicated to continue to develop new and innovative first in class devices to help surgeons achieve better patient outcomes.

About JumpStart Inc.

JumpStart (www.jumpstartinc.org) is a nationally recognized venture development organization that accelerates the progress of high potential, early-stage businesses and includes a special focus on diverse entrepreneurs working in the highest growth industries. Through the depth of its entrepreneurial team and the breadth of its high value resources, JumpStart improves client success in achieving significant milestones, including raising the follow-on capital necessary to create wealth. JumpStart strives to create a more prosperous future for Northeast Ohio. As part of its
'/>"/>

SOURCE JumpStart, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Michael J. Fox Foundation Awards Up to $3 Million to Industry Teams to Jumpstart Promising PD Drug Development
2. Kansas Invests Millions in Innovations to Improve Human Health and Launches Three National Bioscience Programs at BIO08
3. 7 Health Ventures Invests in Tulip Medical
4. Foundation Venture Capital Group Invests in UMDNJ Company Working to Improve Leukemia Treatments
5. Merial invests US $70 million in Nanchang, China
6. Innocoll Announces Dosing of First Patient in US Phase 3 Clinical Trial to Investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections in Cardiac Surgery Patients
7. Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-operative Pain
8. Portrait(R) Plasma - A New Non-Surgical Option for one of the Most Requested Aesthetic Treatment - Aging Eyes
9. New Non-Surgical Stem-Cell Procedure to Relieve Chronic Tendon Problems
10. Ceremeds OSTENE(R) Stops Bone Bleeding Without Added Risk of Surgical Infection, New Study Finds
11. Innocoll Announces Dosing of First Patient in Second US Phase 3 Clinical Trial to Investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)..., FRANKLIN LAKES, N.J., Nov. 20 /PRNewswire-FirstC... BDX ) today announced the completion of its acqu...based company that develops and manufactures molec..., In May 2009, BD and HandyLab announced an exc...ze molecular assays on the HandyLab Jaguar(TM) pla...
(Date:11/20/2009)..., PRINCETON, N.J., Nov. 20 /PRNewswire-FirstCall...oligenix or the Company), formerly known as DOR Bi... announced today that it has formed a consortium t...(TM) and other rapidly acting vaccines. Soligenix ...stitute of Allergy and Infectious Diseases (NIAID)...
(Date:11/19/2009)..., BIRMINGHAM, Ala., Nov. 19 /PRNewswire-FirstCal...X ) today announced the pricing of a public offeri...5 per share, resulting in gross proceeds of $48.75...BioCryst pursuant to an effective shelf registrati...and Exchange Commission. BioCryst has also grante...
Breaking Medicine Technology:BD Completes Acquisition of HandyLab, Inc. 2BD Completes Acquisition of HandyLab, Inc. 3Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 2Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 3Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 4Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 5Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 6BioCryst Announces Pricing of Public Offering of Common Stock 2BioCryst Announces Pricing of Public Offering of Common Stock 3Essentialis to Submit SPA for Hypertriglyceridemia 4847 1Essentialis to Submit SPA for Hypertriglyceridemia 4847 2West to Present at the Ninth Annual CJS Securities New Ideas Summer Conference 54267 13SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 13SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 23SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 33SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 43SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 53SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 63SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 73SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 83SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 93SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 103SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 113SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 123SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 133SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 143SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 153SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 163SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 173SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 183SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 193SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 203SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 213SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 223SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 233SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 243SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 25
(Date:11/20/2009)...ings in children with chronic kidney disease often... office visits increasing a child,s risk for seri...ns Hopkins Children,s Center and other institution...Journal of American Society of Nephrology. , R...tained during regular doctor visits to readings ob...
(Date:11/20/2009)...severe cases than with seasonal flu , ,...archers are reporting that children with asthma ar...than seasonal flu. , "Asthma has been identifie...pandemic H1N1 influenza, present in 21 percent to ... Allen and fellow researchers from the Hospital fo...
(Date:11/20/2009)...W, Calif., Nov. 20 Omnic...ystem solutions to acute healthcare facilities, an...t Annual Piper Jaffray Healthcare Conference at t...mnicell Speakers: Randall A. Lipps, founder, chai...dent & CFO ,, Date: Tuesday, December 1, ...
(Date:11/20/2009)... Nov. 20 The US governm...ruggled to get enough food to eat. This startling...ults who are rapidly aging into poverty. "Forced ... divorce mean many have incomes that no longer cov...e. Older women are particularly vulnerable," said...
(Date:11/20/2009)...Nov. 20 Reportlinker.com announces... its catalogue. ,, Oncology Roadmap: Brand Spe..., http://www.reportlinker.com/p0164998/Oncology-...ast-to-2013.html#utm_source=prnewswire&utm_med...ensive Forecasts and Detailed Budget Benchmarks ne...
Breaking Medicine News(10 mins):Health News:High blood pressure easy to miss in children with kidney disease 2Health News:Omnicell to Present at Piper Jaffray Healthcare Conference 2Health News:Reportlinker Adds Oncology Roadmap: Brand Spending Benchmarks and Market Forecast to 2013 2Health News:Reportlinker Adds Oncology Roadmap: Brand Spending Benchmarks and Market Forecast to 2013 3
...novel study conducted to analyze the fluctuations ...evealed that it may vary over different seasons wi...further supported by the fact that there is a corr...ted the study. Numerous studies have been co...
...ericans consume far too much sodium, putting them ... stroke, according to a new study published in the...ve Medicine. // Although people who already ...levels, according to lead researcher Umed Ajani, a...
...rein van der Torn and his colleagues at the Vrije ...University of Groningen developed a new mechanism ...t cancer the larynx or the voice box as it is call...alve is implanted in-between the windpipe and oeso...
...e Indian State of Uttar Pradesh’s Firozabad Distri...ite of having taken preventive measures, several h... by the disease //which causes cold, fever and dia...ictims to the disease. Interestingly, even medicin...
...e most popular movie ‘Stuart Little’ may no longer... has been proved from experiments// that it is tec...e with the currently available scientific techniqu...perimental animal such as mice. Scientists from Ca...
...urvedic medicines exported from India to Canada ha...ed on 18 types of Ayurvedic medicines by the Canad...n because the samples which were tested contained ...aring the presence of those heavy metals. The pr...
Other Medicine News:Health News:Seasonal Variation In Exercise And Eating Habits Identified 2Health News:Americans Consume Far Too Much Salt and Sodium 2Health News:Chicken pox Spreads Across Firozabad 2Health News:Mice With Human Thought Processes Could Be Developed In The Future 2
BioPro® Uni Knee, Total Resurfacing Preserves Bone Stock
...articulation maintains full inter-changeability. M...tions for better patient fit. The Maxim Knee syst...epts with expanded options to address surgeon pref...or use in total knee replacements both in primary ...
...erchangeability between femoral and tibial compone...ibial component with a durable cobalt chrome femor...GC® Knee is indicated for use in total knee re...ions are required. Unique Cam-and-Groove Posterior...
...laser combines excellent cutting, ablation and coa...ss procedures. It is also extremely effective in f...compositions, making it an ideal multipurpose surg...through flexible fibers, it is especially suited f...
Medicine Products: